Nama Insights

Zoetis Inc. (ZTS)

Healthcare · Drug Manufacturers Specialty Generic · NYSE

S&P 500
Zoetis Inc. (ZTS) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $30.02B, a trailing price-to-earnings ratio of 11.0 and a free-cash-flow yield of 7.1%. Over the most recent reported fiscal year, revenue grew 2.3% and free cash flow per share grew 1.8%.
Market cap$30.02B
Trailing P/E11.0
FCF yield7.1%
Revenue growth (YoY)+2.3%
EPS growth (YoY)+8.4%
FCF/share growth (YoY)+1.8%
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers Specialty Generic
Explore live ZTS data on Nama Insights →

Recent Congressional trades

Zoetis Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Gilbert Cisneros House Buy $1,001 - $15,000 Jul 2, 2026
Byron Donalds House Buy $1,001 - $15,000 Jul 1, 2026
Gilbert Cisneros House Buy $1,001 - $15,000 Dec 12, 2025
Rick Larsen House Sell $1,001 - $15,000 Oct 7, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
Lisa McClain House Sell $1,001 - $15,000 Aug 13, 2025
Rob Bresnahan House Buy $1,001 - $15,000 May 15, 2025
Julie Johnson House Sell $1,001 - $15,000 May 6, 2025
Rob Bresnahan House Sell $1,001 - $15,000 Apr 8, 2025
Jefferson Shreve House Buy $15,001 - $50,000 Mar 28, 2025
Rob Bresnahan House Sell $1,001 - $15,000 Feb 25, 2025
Jared Moskowitz House Sell $1,001 - $15,000 Jul 31, 2024